Building Biotechs · 2024-12-11 · 34 min
This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups. Get Russ's recommended book! Freakonomics: A Rogue Economist Explores the Hidden Side of Everything Learn more about LifeSci Catalyst Partners!
Putting the “Tech” in Biotech: An Unconventional Path to Building a Therapeutics Company, with Federico Paoletti, PhD72 / 100
Accelerating Drug Development is a Moral Imperative with Dr. Gabi Hanna, MD
Funding, Partnerships, and Growth: Strategies for Startup Biotech Success with Fractional Chief Business Officer Renee Williams
Trust, Teamwork, and Innovation, with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics
The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacy Frye, co-founder and CCO of Stimulus Bio